Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Wouldn’t You Buy These Cash-Rich Companies?: Zynga Inc (ZNGA) and More

Page 1 of 2

The balance sheet is the best financial statement to get a quick snapshot of a company’s overall financial health. It shows you accumulation of all profits, expenses, debts, and retained earnings the company has accumulated up to that point — which makes it a great place to quickly scan for signs of a potential winning investment. With balance sheets boasting minimal to no debt and strong net cash positions, the three stocks below might be worth a closer look.

Will Zynga Inc (NASDAQ:ZNGA) Actually Move Higher?

This is a question many investors have been asking of the social media video game maker. It has barely been public more than a year, but it’s already down approximately 80% from its $15.91 all-time high, and approximately 65% since it went public on December 16, 2011.

Zynga Inc (NASDAQ:ZNGA)The company has had a recent exodus of senior managers, most recently Chief Game Designer Brian Reynolds, and investors remain quite skeptical about its future revenue growth. So why would anybody buy the stock?

That can be answered in one word: cash.  In its most recent quarter, Zynga reported having approximately $1.3 billion in cash against only $100 million in debt. That means the company is approximately 50% net cash at its current trading price — a very strong net cash position.

In addition, the company has operationally performed rather well, meeting or exceeding analyst estimates in three of its last four quarters. Moreover, those same analysts expect a strong 20% per annum revenue growth over the next five years. Lastly, with a relatively cheap enterprise value/EBITDA valuation of 1x, and the company’s positive free cash flow near $20 million the last quarter, I think investors have some legitimate optimism with the stock.

If you’re looking to diversify this position with another cash-rich video game maker, look no further than Activision Blizzard, Inc. (NASDAQ:ATVI). The company just recently scorched higher on a blowout earnings report that smashed consensus estimates by $0.06. Its diversified video game lineup seems to be working out well for the firm, which currently enjoys great success with Call of Duty and Skylanders.  However, as Activision sits at a new 52-week high, should we buy the stock as well?

Activision has in fact smashed consensus earnings estimates in each of the last four quarters by an average of 53.3%, giving us a clear indication that the company is firing on all cylinders. Moreover, with a debt-free balance sheet and approximately $4 per share in net cash, the company has a very strong financial position. Its relatively strong 30% operating margins and 1.4% dividend yield make it all the more tempting. And its mouth-watering free cash flow, at approximately $1 billion annually, gives me a final reason to believe that Activision is a winner.

Is It Time to Finally Buy Groupon Inc (NASDAQ:GRPN) ?

I don’t know about you, but I have used Groupon Inc (NASDAQ:GRPN)’s services frequently; they simply provide a nice product at a great price. Unfortunately, like Zynga, the stock has been horrendous, down approximately 80% from its IPO on Nov. 4, 2011. Fortunately, though, like Zynga, it has a sterling balance sheet: absolutely no debt, and just over $1.80 per share in net cash. Does this mean it is time to buy Groupon as well?

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!